Stock vs Stock Comparison

AstraZeneca PLC vs Eli Lilly and Company

AZN and LLY are evenly matched across key metrics.

AZN$176.28
LLY$1078.78

🏆 Tale of the Tape

44
AZNLLY
17.4%Profitability (Net Margin)31.7%
27.9xValuation (P/E)39.2x
13.3%Efficiency (ROIC)30.4%
7/9Health (Piotroski F)7/9
3.9Safety (Altman Z)7.8
8.6%Growth (Rev YoY)44.7%
1.61Risk (Sharpe 1Y)0.61
1.34xBalance Sheet (D/E)3.24x
2.59%FCF Yield0.68%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.422
252-Day Correlation
0.337
126-Day Correlation

Moderately correlated — some diversification benefit from holding both.

Fundamentals

MetricAZNLLY
Market Cap$287.9B$985.4B
P/E Ratio27.9x39.2x
Forward P/E23.1x24.8x
P/B6.08x31.65x
Dividend Yield1.70%0.63%
Beta0.220.48

Quantitative Metrics

MetricAZNLLY
DCF Fair Value$132.90$296.11
DCF Upside-34.3%-68.2%
Piotroski F7/97/9
Altman Z3.947.84
Beneish M-1.91
FCF Yield2.59%0.68%
Net Debt/EBITDA1.0x1.1x
ROIC13.3%30.4%
WACC7.7%7.8%
ROIC – WACC5.6pp22.5pp
Gross Margin81.9%83.0%
Net Margin17.4%31.7%
Rev Growth YoY8.6%44.7%
Sharpe (1Y)1.610.61
Max Drawdown 3Y-27.9%
FCF Payout Ratio57%90%

AZN Price

Loading chart...

LLY Price

Loading chart...

ETF Exposure

AZN found in:

VGK1.81%
VSGX1.01%
VEA0.90%
SPDW0.88%
CWI0.78%
VEU0.71%
VXUS0.65%
VT0.25%

LLY found in:

XLV15.40%
IYH13.72%
VHT12.15%
VIG3.33%
SCHG3.17%
QUAL2.92%
MGK2.82%
IWF2.66%
VONG2.42%
SPYG2.36%
VUG2.31%
IVW2.23%
QUS1.95%
XPH1.90%
ESGV1.48%
DGRW1.46%
IVV1.46%
SCHX1.34%
SPY1.29%
ITOT1.29%
SCHB1.25%
VFQY1.23%
VOO1.20%
SPTM1.20%
VTI1.14%
VONE1.14%
SPLG1.10%
ARKG1.04%
URTH0.99%
ACWI0.87%
VT0.66%
VFMO0.46%
RSP0.20%
ONEO0.02%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

AZN vs LLY: Head-to-Head Analysis

AstraZeneca PLC (AZN) and Eli Lilly and Company (LLY) represent two companies in the Healthcare sector. Our quantitative Tale of the Tape shows these companies are evenly matched across profitability, valuation, and risk metrics.

In terms of capital efficiency, AZN generates a return on invested capital (ROIC) of 13.3% compared to LLY's 30.4%. This suggests LLY is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between AZN and LLY is 0.422, indicating moderate co-movement, with some diversification value from holding both in a portfolio context.

AZN appears in 8 ETFs tracked by SecuritiesDB, while LLY appears in 34 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, AZN or LLY?

Our quantitative analysis compares AZN and LLY across nine fundamental dimensions. AZN and LLY are evenly matched across key metrics. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are AZN and LLY correlated?

The 252-day correlation between AZN and LLY is 0.422. They show moderate correlation — partially diversifying.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.